PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 20, 2026American Journal of Respiratory and Critical Care Medicine0 citations

C28-21 Trends in Pulmonary Embolism-related Mortality Among Patients With Pneumonia in the United States: A CDC Wonder Analysis (1999-2023)

View Full Paper
FZF ZakariaMAM AlaliLSL Sarupani

Key Result

Age-adjusted mortality rates for coexisting pneumonia and pulmonary embolism in the US increased from 0.81 in 1999 to 1.21 per 100,000 in 2023, with an average annual increase of 1.16%.

Key Points

  • This study aims to investigate national and demographic trends in mortality associated with pneumonia and pulmonary embolism in the United States from 1999 to 2023.
  • Mortality data were analyzed from the CDC WONDER database spanning 1999 to 2023.
  • Age-adjusted mortality rates for pneumonia and pulmonary embolism were calculated among adults aged ≥25 years.
  • Joinpoint regression analysis determined the annual percent change in mortality rates.
  • Total deaths related to pneumonia and pulmonary embolism were 59,839 between 1999 and 2023.
  • The overall age-adjusted mortality rate increased from 0.81 in 1999 to 1.21 in 2023, with an average annual increase of 1.16%.
  • Males had higher mortality rates (1.26) compared to females (0.88), with highest rates in the 85+ age group (10.07).

Study Design

Type

Observational (n=59,839)

Multicenter

Yes

Structured PICO

P
Population
Adults aged ≥25 years in the United States with mortality related to pneumonia and pulmonary embolism between 1999 and 2023 (n=59,839 deaths).
O
Outcome
Age-adjusted mortality rates (AAMRs) for pneumonia and pulmonary embolism per 100,000 populationhard clinical

Mortality related to coexisting pneumonia and pulmonary embolism in the US increased significantly from 1999 to 2023, with disproportionately higher rates in males, non-Hispanic Black individuals, and older adults.

Main Result

Effect estimate: Average annual increase 1.16%

Absolute Event Rate: 1.21% vs 0.81%

Abstract

Abstract Rationale Pneumonia and pulmonary embolism (PE) frequently coexist, as pulmonary inflammation and infection heighten the risk of thrombosis and compromise circulation. Comprehensive investigation of these interconnected conditions is vital, as their coexistence markedly worsens clinical outcomes and elevates mortality. This study aims to examine national, demographic and geographic trends in mortality associated with pneumonia and pulmonary embolism in the United States from 1999 to 2023. Methods Mortality data were obtained from the CDC WONDER database for the years 1999 to 2023. Age-adjusted mortality rates (AAMRs) for pneumonia (ICD-10 code: J18.9) and pulmonary embolism (ICD-10 code: I26) were analyzed among adults aged ≥25 years in the United States per 100,000 population. Data were stratified by year, gender, race, age and geographic regions. Joinpoint regression analysis was used to calculate the annual percent change (APC) and average annual percent change (AAPC) to evaluate long-term national mortality trends. Results Between 1999 and 2023, there were a total of 59,839 deaths related to pneumonia and pulmonary embolism. The overall AAMR increased from 0.81 (95% CI, 0.77-0.85) in 1999 to 1.21 (95% CI, 1.21-1.30) in 2023, with an average annual increase of 1.16%. Males had higher mortality rates than females (AAMR males: 1.26 vs. females: 0.88). When stratified by age, highest mortality was noted in the 85+ year age group (10.07). Among racial groups, the non-Hispanic Blacks (1.51) had the highest AAMR, followed by Whites (1.04) and finally Hispanics (0.79). Regionally, the Southern region exhibited the highest AAMR (1.14), followed by the Midwestern region (1.11), Western region (1.09) and finally the Northeastern region (0.84). Non-metropolitan areas exceeded metropolitan areas (1.08 vs. 0.85). Similarly, the highest AAMRs were observed in West Virginia (2.78) and lowest in Maine (0.60). Conclusion This study demonstrates a marked increase in age-adjusted mortality rates among patients with pneumonia and pulmonary embolism between 1999 and 2023. Mortality rates were disproportionately higher among males and non-Hispanic Black individuals, with significant regional variation observed, particularly in the Southern and Midwestern regions. The majority of all recorded deaths occurred in individuals aged 85 years and older. These findings highlight the urgent need for improved prevention and management, alongside continued research to clarify genetic, socioeconomic, and environmental drivers of racial, ethnic, and regional mortality disparities, guiding more targeted and equitable interventions. This abstract is funded by: None

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Zakaria et al. (2026) conducted an observational in Pneumonia and pulmonary embolism (n=59,839). Age-adjusted mortality rates for coexisting pneumonia and pulmonary embolism in the US increased from 0.81 in 1999 to 1.21 per 100,000 in 2023, with an average annual increase of 1.16%.

synapsesocial.com/papers/6a0d4f62f03e14405aa9ababhttps://doi.org/10.1093/ajrccm/aamag162.4428
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Trends and Disparities in Pulmonary Embolism Mortality in the United States, 1999– 20232025
  2. 2Sex, Racial, and Geographic Disparities in Pulmonary Embolism–related Mortality Nationwide2023 · 38 citations
  3. 3Mortality trends in the United States for adults with concurrent cerebrovascular disease and pulmonary embolism2026
  4. 4Trends in mortality from deep vein thrombosis and pulmonary embolism as multiple causes of death in u.S. adults aged ≥65 years (1999–2023): A CDC wonder analysis2025 · 1 citations
  5. 5Trends in pulmonary embolism mortality rates by age group in the United States, 1999–20192022 · 11 citations